Global, regional, and national burden of glucose-6-phosphate dehydrogenase (G6PD) deficiency from 1990 to 2021: a systematic analysis of the global burden of disease study 2021
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency remains a significant global health burden, particularly in malaria-endemic regions. Despite advances in diagnostic capabilities and treatment strategies, the prevalence and associated disability burden continue to evolve. This study provides a comprehensive assessment of the global, regional, and national burden of G6PD deficiency from 1990 to 2021, using the Global Burden of Disease (GBD) 2021 database. Methods: Data were retrieved from GBD 2021, covering 204 countries and territories. Prevalence, incidence, and years lived with disability (YLDs) were analyzed. Age-standardized rates (ASRs) and estimated annual percentage change (EAPC) were computed to assess trends over time. The relationship between socio-demographic index (SDI) and G6PD burden was examined using Spearman correlation analysis. Results: In 2021, global prevalence reached 443,326,869 cases, an 80.17% increase from 1990. The highest burden was observed in South Asia, accounting for 138,159,940 cases. The largest percentage increase in prevalence was in Andean Latin America (+291.96%). G6PD deficiency burden was negatively correlated with SDI, but high SDI regions exhibited higher prevalence than expected. Age- and sex-specific analysis revealed a higher burden in males, particularly in childhood and older age groups. Conclusion: This study underscores the growing burden of G6PD deficiency, with substantial regional disparities. The findings emphasize the need for improved screening programs, policy interventions, and resource allocation in low- and middle-income countries (LMICs). Continued surveillance is essential to mitigate the long-term health consequences of this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An elevation in population diversity, diagnostic approach modification, and migration contribute to the G6PDd discrepancy and the requirement of conducting the latest surveillance.”
From Pooled prevalence of Glucose-6-phosphate dehydrogenase deficiency among malaria patients in Ethiopia: a systematic review and meta-analysis (2026) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferrari, A. J., Santomauro, D. F., Aali, A., Abate, Y. H., Abbafati, C., Abbastabar, H., Abd ElHafeez, S., Abdelmasseh, M., Abd-Elsalam, S., Abdollahi, A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00757-8 · Cited by 5,112
Naghavi, M., Ong, K. L., Aali, A., Ababneh, H. S., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasian, M., Abbasi-Kangevari, M., Abbastabar, H., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00367-2 · Cited by 2,889
Brauer, M., Roth, G. A., Aravkin, A. Y., Zheng, P., Abate, K. H., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasi, M. A., Abbasian, M., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00933-4 · Cited by 2,884
Glucose-6-phosphate dehydrogenase deficiency
Cappellini, M., & Fiorelli, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60073-2 · Cited by 1,590
Bancone, G., Gornsawun, G., Chu, C. S., Porn, P., Pal, S., Bansil, P., Domingo, G. J., & Nosten, F. (2018) · PLOS ONE · doi:10.1371/journal.pone.0196716 · Cited by 65
Research works printed but not linked: 27
- Arain, 2014, Prevention of Kernicterus in South Asia: role of neonatal G6PD deficiency and its identification, Indian J. Pediatr., 81, 599, 10.1007/s12098-014-1410-y · DOI
- Awab, 2021, Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria, Elife, 10, 10, 10.7554/elife.62448 · DOI
- Chu, 2018, Primaquine-induced haemolysis in females heterozygous for G6PD deficiency, Malar. J., 17, 101, 10.1186/s12936-018-2248-y · DOI · Paper page
- Ciavarella, 2025, Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics, Lancet Infect. Dis, 10.1016/S1473-3099(24)00689-3 · DOI
- Clarke, 2017, Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia, Elife, 6, e15085, 10.7554/eLife.15085 · DOI
- Dore, 2021, The elderly with glucose-6-phosphate dehydrogenase deficiency are more susceptible to cardiovascular disease, J. Atheroscler. Thromb., 28, 604, 10.5551/jat.56531 · DOI
- Galatas, 2017, Heterogeneity of G6PD deficiency prevalence in Mozambique: a school-based cross-sectional survey in three different regions, Malar. J., 16, 36, 10.1186/s12936-016-1674-y · DOI
- Goyal, 2015, Newborn screening for G6PD deficiency: a 2-year data from North India, Indian J. Public Health, 59, 145, 10.4103/0019-557X.157537 · doi:10.4103/0019-557x.157537
- Kuupiel, 2020, Geographical accessibility to glucose-6-phosphate dioxygenase deficiency point-of-care testing for antenatal care in Ghana, Diagnostics (Basel), 10, 229, 10.3390/diagnostics10040229 · DOI
- Kwiatkowski, 2005, How malaria has affected the human genome and what human genetics can teach us about malaria, Am. J. Hum. Genet., 77, 171, 10.1086/432519 · DOI · Paper page
- LaRue, 2014, Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency, Am. J. Trop. Med. Hyg., 91, 854, 10.4269/ajtmh.14-0194 · DOI · Paper page
- 2014, Reappraisal of known malaria resistance loci in a large multicenter study, Nat. Genet., 46, 1197, 10.1038/ng.3107 · DOI · Paper page
- Mukherjee, 2015, Glucose-6-phosphate dehydrogenase (G6PD) deficiency among tribal populations of India - country scenario, Indian J. Med. Res., 141, 516, 10.4103/0971-5916.159499 · DOI
- Pal, 2019, Evaluation of a novel quantitative test for glucose-6-phosphate dehydrogenase deficiency: bringing quantitative testing for glucose-6-phosphate dehydrogenase deficiency closer to the patient, Am. J. Trop. Med. Hyg., 100, 213, 10.4269/ajtmh.18-0612 · DOI · Paper page
- Pao, 2005, Neonatal screening for glucose-6-phosphate dehydrogenase deficiency, Indian J. Pediatr., 72, 835, 10.1007/BF02731109 · doi:10.1007/bf02731109
- Pukrittayakamee, 2024, Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers, Elife, 12, 10.7554/eLife.87318 · doi:10.7554/elife.87318
- Sadhewa, 2025, Performance of quantitative point-of-care tests to measure G6PD activity: an individual participant data meta-analysis, PLoS Negl. Trop. Dis., 19, e0012864, 10.1371/journal.pntd.0012864 · DOI
- Stykel, 2025, G6PD deficiency triggers dopamine loss and the initiation of Parkinson's disease pathogenesis, Cell Rep., 44, 115178, 10.1016/j.celrep.2024.115178 · DOI
- Sulistyaningrum, 2020, Prevalence of glucose 6-phosphate dehydrogenase variants in malaria-endemic areas of south central timor, eastern Indonesia, Am. J. Trop. Med. Hyg., 103, 760, 10.4269/ajtmh.19-0780 · DOI
- Tabatabaei, 2015, Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in southeast Iran: implications for malaria elimination, J. Infect. Dev. Ctries., 9, 289, 10.3855/jidc.5572 · DOI
- Tang, 2024, Incidence trends of inherited anemias at the global, regional, and national levels over three decades, J. Epidemiol. Glob. Health, 14, 72, 10.1007/s44197-023-00170-9 · DOI
- Taylor, 2023, Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial, Lancet Infect. Dis., 23, 471, 10.1016/S1473-3099(22)00658-2 · DOI
- Watson, 2017, Modelling primaquine-induced haemolysis in G6PD deficiency, Elife, 6, e23061, 10.7554/eLife.23061 · DOI · Paper page
- Watson, 2019, Collider bias and the apparent protective effect of glucose-6-phosphate dehydrogenase deficiency on cerebral malaria, Elife, 8, e43154, 10.7554/eLife.43154 · DOI
- Xuan-Rong Koh, 2023, Prevalence and molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Senoi Malaysian Orang Asli population, PLoS One, 18, e0294891, 10.1371/journal.pone.0294891 · doi:10.1371/journal.pone.0294891
- Zhou, 2024, Evaluating the relationship between Clinical G6PD enzyme activity and gene variants, PeerJ, 12, e16554, 10.7717/peerj.16554 · doi:10.7717/peerj.16554
- Zobrist, 2021, Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil, PLoS Negl. Trop. Dis., 15, e0009649, 10.1371/journal.pntd.0009649 · DOI
Cited by
Dessie, G., Getnet, M., Getahun, A. B., Mengstie, T. A., Asefa, T., Enyew, E. F., Yewodiaw, T. K., Endale, H. T., & Endalew, H. L. (2026) · Malaria Journal · doi:10.1186/s12936-026-05800-8
Metadata
- Authors
- Yu, Z., Xiong, Q., Wang, Z., Li, L., & Niu, T.
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2025-05-23
- Volume
- 16
- ISSN
- 1664-8021
- Cited by
- 21
- References
- 5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global, regional, and national burden of glucose-6-phosphate dehydrogenase (G6PD) deficiency from 1990 to 2021: a systematic analysis of the global burden of disease study 2021. https://app.cochat.ai/papers/10.3389/fgene.2025.1593728
- The paper
- Yu, Z., Xiong, Q., Wang, Z., Li, L., & Niu, T. (2025). Global, regional, and national burden of glucose-6-phosphate dehydrogenase (G6PD) deficiency from 1990 to 2021: a systematic analysis of the global burden of disease study 2021. Frontiers in Genetics. https://doi.org/10.3389/fgene.2025.1593728
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.